BrainTransporter™ dramatically improves antibody delivery to the brain

Contributed by: PR Newswire

Tags

BioArctic

More Like This

BioArctic and Eisai sign research evaluation agreement regarding BAN2802

BioArctic: New data on lecanemab presented at the 2024 AD/PD™ congress

BioArctic: Latest data on lecanemab to be presented at the 2024 AD/PD™ congress

Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs

BioArctic: Professor Lars Lannfelt, awarded Fondation Recherche Alzheimer's European Grand Prix for his contributions to science and treatment of Alzheimer's disease

Regarding rumors of an imminent approval of lecanemab in Great Britain: BioArctic

Lecanemab data presented at CTAD on early initiation and long-term treatment suggest increased patient benefit with maintained safety profile

PartitionBio™ awarded grant to exploit its novel biologics shuttle platform for therapeutic nucleic acids delivery